Posttherapy Hypokalemia

Baseline plasma aldosterone concentration is independently associated with clinical and biochemical outcomes of treatment among adults with primary aldosteronism, and data suggest that mineralocorticoid receptor antagonist therapy is the optimal strategy vs. adrenalectomy for those with a normal plasma aldosterone concentration, according to findings published in the Journal of the Endocrine Society.